Second Sight Leaves Patients with Obsolete Implants

As the company prepares to merge and pivot, 350+ people with Argus II implants will soon be left in the dark.

In 2013, the FDA approved Second Sight Medical’s Argus II, a retinal prosthesis that provides artificial vision by converting images into electrical pulses that can be read by the brain. More than 350 people worldwide received the implant over the last decade, but according to a recent FierceBiotech article, the company has left the users high and dry. Due to financial issues, Second Sight began phasing the Argus II out in 2019. This month, the process was expedited amid the company’s plan to pivot and merge with Nano Precision Medical, a drug delivery implant maker. 

Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Sustainable Healthcare Packaging Solutions That Work